Skip to main content
Rashna Madan, MD, Pathology, Kansas City, KS

Rashna Madan MD

Cytopathology, Anatomic Pathology, Clinical Pathology


Assistant Professor, Pathology and Laboratory Medicine, University Kansas

Join to View Full Profile
  • 4000 Cambridge StKansas City, KS 66160

  • Phone+1 913-588-1227

  • Fax+1 913-588-7073

Are you Dr. Madan?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Rashna Madan, MD is a board certified pathologist in Kansas City, Kansas. She is currently licensed to practice medicine in Kansas and Connecticut. She is an Assistant Professor at University Kansas.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 2006 - 2007
  • Memorial Sloan Kettering Cancer Center Oncologic Pathology
    Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2005 - 2006
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 2001 - 2005
  • Kasturba Medical College Manipal
    Kasturba Medical College ManipalClass of 1996

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2007 - 2025
  • CT State Medical License
    CT State Medical License 2005 - 2008
  • Anatomic Pathology & Clinical Pathology
    American Board of Pathology Anatomic Pathology & Clinical Pathology
  • Cytopathology
    American Board of Pathology Cytopathology

Publications & Presentations

PubMed

Press Mentions

  • Targeted Inhibition of Histone Deacetylase Leads to Suppression of Ewing Sarcoma Tumor Growth Through an Unappreciated EWS-FLI1/HDAC3/HSP90 Signaling Axis
    Targeted Inhibition of Histone Deacetylase Leads to Suppression of Ewing Sarcoma Tumor Growth Through an Unappreciated EWS-FLI1/HDAC3/HSP90 Signaling AxisApril 25th, 2019